Greg Madison, President and CEO at KERYX BIOPHARMACEUTICALS INC (KERX), sold 910 shares at $7.67 ($7K) on 2017-07-05, disclosed to the SEC on 2017-07-06.
Open-market sale of $7k KERX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KERX | SELL | 2017-10-31 | $24K | — | Filing → |
| KERX | SELL | 2017-10-06 | $6K | — | Filing → |
| KERX | SELL | 2017-08-01 | $29K | — | Filing → |